MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, insurance bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
IPO Year: 2020
Exchange: NYSE
Website: multiplan.us
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $2.00 | Neutral | Piper Sandler |
12/13/2022 | $3.00 → $2.00 | Buy → Neutral | Citigroup |
7/12/2022 | $6.50 | Neutral | Goldman |
12/20/2021 | $9.00 → $7.00 | Buy | Citigroup |
11/11/2021 | $7.00 → $6.00 | Equal-Weight | Barclays |
10/4/2021 | $9.00 | Buy | Citigroup |
8/20/2021 | $9.00 | Buy | Tigress Financial |
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, and hold its conference call that morning at 9:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=f096f8c3&confId=66913. Upon registration, you will receive an email with the conference dial-in details and
Company's PlanOptix™ and BenInsights™ solutions recognized for reducing healthcare costs MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced it has been selected as the Gold award winner in the "Achievement in Data and Analytics" category of the 9th annual Globee® Awards for American Business. MultiPlan's PlanOptix™ and BenInsights™ solutions were selected for their impact on driving excess costs and overpayments out of the healthcare system. We believe this award is a testame
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions, to the U.S. healthcare industry, today announced that Great Place To Work® and Fortune magazine have recognized the Company as one of the Best Workplaces in New York™ for 2024. This marks the second consecutive year MultiPlan has been named to this prestigious list. "Our inclusion on this list makes clear the unwavering investment we make in our employees' long-term success," said Carol Nutter, SVP and Chief People Officer at MultiPlan. "MultiPlan prides itself on maintainin
Second annual report highlights the company's ongoing commitment to social and environmental stewardship MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced the publication of its 2023 Environmental, Social, and Governance (ESG) Report. The report follows the release of its inaugural ESG report last year, which detailed the structured assessment and reporting approach the Company undertakes to identify, prioritize, and monitor ESG risks and opportunities. The 2023 report showc
MultiPlan's PlanOptix™ Platform Recognized for Bringing Price Transparency to the Market MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that its PlanOptix™ platform has been named the winner of the "Best Overall Healthcare Data Analytics Platform" award in the 2024 MedTech Breakthrough Awards program. MultiPlan's PlanOptix™ platform was selected for its ability to provide prescriptive analytics and applications to help clients make more informed decisions in the context o
– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK Notes MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today r
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that members of its management team will participate in person at the following conferences in May 2024: Goldman Sachs Ninth Annual Leverage Finance and Credit Conference – Tuesday, May 14th, 2024, at the Terranea Resort, Rancho Palos Verde, CA Bank of America Healthcare Conference – Wednesday, May 15, 2024, at the Encore Wynn, Las Vegas, NV (including a fireside chat at approximately 5:20 pm Eastern Time) Barclays Leverage Finance Conference – Tuesday,
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its first quarter 2024 financial results on Wednesday, May 8, 2024, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, go to:
– Company has six months to regain compliance with the minimum price criteria for continued listing on the NYSE – Company remains focused on executing its Growth Plan and on delivering results and shareholder value MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company") announced today that it received notice (the "Notice") on March 28, 2024 from the New York Stock Exchange (the "NYSE") that, as of March 27, 2024, it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE's Listed Company Manual ("Section 802.01C") because the average closing price of the Company's Class A Common Stock (the "Common Stock") was less than $1.00 per share
Hogge's Growth-Driven Expertise Bolsters MultiPlan's Next Phase of Growth and Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that Jerry Hogge will join the Company as Executive Vice President, Chief Operating Officer (COO). Hogge is a highly accomplished operational and commercial leader who has excelled within the healthcare and telecommunications industries for over 30 years. He has a wide range of experience driving operational efficiency and growth in compl
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions, to the U.S. healthcare industry, today announced that Great Place To Work® and Fortune magazine have recognized the Company as one of the Best Workplaces in New York™ for 2024. This marks the second consecutive year MultiPlan has been named to this prestigious list. "Our inclusion on this list makes clear the unwavering investment we make in our employees' long-term success," said Carol Nutter, SVP and Chief People Officer at MultiPlan. "MultiPlan prides itself on maintainin
Hogge's Growth-Driven Expertise Bolsters MultiPlan's Next Phase of Growth and Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that Jerry Hogge will join the Company as Executive Vice President, Chief Operating Officer (COO). Hogge is a highly accomplished operational and commercial leader who has excelled within the healthcare and telecommunications industries for over 30 years. He has a wide range of experience driving operational efficiency and growth in compl
Transition Aligned with Company's Growth Strategy and Next Phase of Product Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, announced that Travis Dalton will join the Company as President and CEO on March 1, 2024. He will succeed Dale White, who will remain active as Executive Chair of the Company, succeeding current Chair Mark Tabak. With over 20 years in healthcare technology leadership positions at Cerner Corporation and Oracle Health, Mr. Dalton is a proven leader with deep experience in leveraging technology, data
Appointment of new SVP of Marketing and Communications and SVP of Products support the next phase of the Company's Growth Plan MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced the appointment of Melissa Humphrey to Senior Vice President of Marketing and Communications and the promotion of Andrea Rowe to Senior Vice President of Products. As MultiPlan's new SVP of Marketing and Communications, Humphrey will oversee the company's brand reputation, product marketing, client co
Adds significant payor industry expertise and bolsters next phase of company's growth plan MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, today announced the appointment of John Prince to its Board of Directors, effective June 26, 2023. Prince has more than 25 years of executive leadership experience running businesses in healthcare services and technology and managing enterprise functions spanning strategy, corporate development, operations, and technology for healthcare payors and providers, bringing a valuable depth of expertise
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, today announced that Dale White will assume the title of Chief Executive Officer on February 1, 2022 in accordance with the Company's previously announced executive transition plan. Mr. White succeeds Mark Tabak. Since joining MultiPlan in 2004, Mr. White has held a variety of key leadership positions, most recently President and Chief Operating Officer. Along with his elevation to CEO, Mr. White has been appointed as a member of the Board of Directors and will serve as a Class III Dir
Dr. Perryman to prioritize and operationalize data science opportunities across cost-management, payment, and revenue integrity solutions MultiPlan Corporation (NYSE:MPLN) a leading provider of data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, announces the appointment of Benjamin Perryman, PhD, to Vice President, Data Science Operations. In the new position, Dr. Perryman will implement an agile methodology focused on continuous delivery of client-centric analytical insights. Dr. Perryman's appointment is a part of MultiPlan's continued investment in systems and service infrastructure to support the delivery o
Morgan Stanley, BDT & Company veteran brings strategic finance, healthcare, and business development experience to the MultiPlan executive leadership team MultiPlan Corporation (NYSE:MPLN), a leading provider of data analytics and technology-enabled cost management, and payment and revenue integrity solutions to the U.S. healthcare industry, has appointed Jim Head to serve as its new Executive Vice President and Chief Financial Officer, effective November 29, 2021. As of that date, he will replace David Redmond who will retire at the end of 2021, as was announced earlier this year. Head brings significant experience in corporate strategy, mergers and acquisitions, capital markets, and inve
Longo appointment formalizes MultiPlan's end-to-end approach to help healthcare payors comply with No Surprises Act regulations MultiPlan Corporation (NYSE:MPLN), a leading provider of data analytics and technology-enabled cost management, and payment and revenue integrity solutions to the U.S. healthcare industry, announces the appointment of Liz Longo to Vice President, Subrogation & Arbitration Solutions. In this position, Longo will lead MultiPlan's surprise bill arbitration services, a critical component of the No Surprises Act, passed in December 2020. She joined the Company with the acquisition of Discovery Health Partners in March 2021, where she created and led the Company's Subro
Nagiah, seasoned business and product strategist, to bring fresh inspiration and innovation to product development team MultiPlan Corporation (NYSE:MPLN), a leading provider of data analytics and technology-enabled cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced Navin Nagiah as Senior Vice President, Products. In his new role, Nagiah will be responsible for driving the company's internal product development approach, identifying strategic, market-driven innovations, and evaluating external sources for new product and service acquisition opportunities. "I am passionate about converting ideas and needs into products that move the val
Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00
Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously
Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50
Citigroup reiterated coverage of MultiPlan with a rating of Buy and set a new price target of $7.00 from $9.00 previously
Barclays reiterated coverage of MultiPlan with a rating of Equal-Weight and set a new price target of $6.00 from $7.00 previously
Citigroup resumed coverage of MultiPlan with a rating of Buy and set a new price target of $9.00
Tigress Financial initiated coverage of MultiPlan with a rating of Buy and set a new price target of $9.00
B. Riley FBR initiated coverage of MultiPlan with a rating of Buy and set a new price target of $10.00
Barclays initiated coverage of MultiPlan with a rating of Equal Weight and set a new price target of $7.00
4 - MultiPlan Corp (0001793229) (Issuer)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13D/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
8-K - MultiPlan Corp (0001793229) (Filer)
S-8 - MultiPlan Corp (0001793229) (Filer)
10-Q - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
DEFA14A - MultiPlan Corp (0001793229) (Filer)
DEF 14A - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
S-8 - MultiPlan Corp (0001793229) (Filer)
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, and hold its conference call that morning at 9:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=f096f8c3&confId=66913. Upon registration, you will receive an email with the conference dial-in details and
– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK Notes MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today r
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its first quarter 2024 financial results on Wednesday, May 8, 2024, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, go to:
– Q4 2023 Revenues of $244.1 million, Net Loss of $31.4 million and Adjusted EBITDA of $156.8 million – Full Year 2023 Revenues of $961.5 million, Net Loss of $91.7 million and Adjusted EBITDA of $618.0 million – Identified potential medical cost savings of approximately $5.9 billion in Q4 2023, up 2.3% from Q3 2023 and up 9.4% from Q4 2022 – In Full Year 2023, the Company deployed cash of $140.9 million for the acquisition of Benefits Science LLC ("BST"), $165.8 million toward open-market debt repurchases and repayment, and $15.2 million toward share repurchases – Full Year 2024 Revenues guidance of $1,000 million to $1,030 million and FY 2024 Adjusted EBITDA guidance of $630 milli
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To
– Q3 2023 Revenues of $242.8 million, Net Loss of $24.1 million, and Adjusted EBITDA of $152.3 million – Identified potential medical cost savings of approximately $5.8 billion in Q3 2023, up 2% from Q2 2023 and up 7% from Q3 2022 – Repurchased an additional $46.1 million in face value of our 5.75% Senior Unsecured Notes in the open market in Q3 2023 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2023. "The third quarter
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its third quarter 2023 financial results on Tuesday, November 7, 2023, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, go
– Q2 2023 Revenues of $238.0 million, Net Loss of $36.4 million, and Adjusted EBITDA of $152.7 million – Identified potential medical cost savings of approximately $5.7 billion in Q2 2023, up 2% from Q1 2023 – In Q2 2023, acquired Benefits Science Technologies, a leading data science company, and partnered with ECHO Health to offer a B2B healthcare payments service MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the second quarter ended June 30, 2023. "The s
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its second quarter 2023 financial results on Wednesday, August 2, 2023, and hold its conference call that morning at 10:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, g
Ushers in a new era of the company, accelerates launch of new Data & Decision Science service line with a world-class data & analytics platform and team at BST MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, today announced that it has acquired Benefits Science LLC ("Benefits Science Technologies" or "BST"), a next generation data and advanced analytics company that combines modern data science, including machine learning and artificial intelligence ("AI"), with deep expertise in healthcare to deliver solutions that reduce the cost
Piper Sandler analyst Jessica Tassan initiates coverage on MultiPlan (NYSE:MPLN) with a Neutral rating and announces Price Target of $2.
Gainers Anitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million. PACS Group (NYSE:PACS) shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion. MultiPlan (NYSE:MPLN) shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million. Nanoviricides (AMEX:NNVC) stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million. Calidi Biotherapeutics (AME
Shares of Lands’ End, Inc. (NASDAQ:LE) fell sharply during Wednesday's session following first-quarter results. Lands’ End reported quarterly adjusted loss of 20 cents per share which beat the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $285.47 million which beat the analyst consensus estimate of $269.82 million, according to data from Benzinga Pro. Lands’ End shares dipped 9.3% to $12.60 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers Actelis Networks, Inc. (NASDAQ:ASNS) shares jumped 512% to $2.88 after the company announced orders for cyber-hardened networking technology to be deployed at thr
Gainers Concord Medical Services (NYSE:CCM) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. Calidi Biotherapeutics (AMEX:CLDI) stock increased by 4.26% to $0.21. The market value of their outstanding shares is at $10.8 million. Anitra (AMEX:AZTR) shares moved upwards by 2.69% to $0.18. The market value of their outstanding shares is at $5.0 million. MAIA Biotechnology (AMEX:MAIA) stock rose 0.79% to $3.79. The company's market cap stands at $82.7 million. Emergent BioSolutions (NYSE:EBS) shares moved upwards by 0.53% to $5.59. The market value of their outstanding shares is at $292.9 million. Asensus Surg
Shares of GameStop Corp. (NYSE:GME) rose sharply in today's pre-market trading after the company announced it has completed its at-the-market equity offering program, which was previously announced. The company sold 45 million shares under the plan with aggregate gross proceeds of $933.4 million. GameStop shares jumped 17.6% to $22.35 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Sharps Technology, Inc. (NASDAQ:STSS) rose 131.2% to $0.4954 in today's pre-market trading after jumping around 13% on Friday. Calliditas Therapeutics AB (NASDAQ:CALT) shares gained 74.6% to $38.10 in pre-market trading after the company's boar
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 0.5% on Tuesday. Shares of Hello Group Inc. (NASDAQ:MOMO) fell sharply in today's pre-market trading following first-quarter results. Hello Group posted adjusted EPADS of 4 cents, compared to market expectations of 29 cents. The company's sales came in at $354.61 million versus estimates of $347.95 million, according to data from Benzinga Pro. Hello Group shares fell 4.9% to $5.25 in pre-market trading. Here are some big stocks recording losses in today's pre-market trading session. MultiPlan Corporation (NYSE:MPLN) shares dipped 9.8% to $0.6198 in pre-market trading after jumping 22% o
Gainers Innovative Eyewear (NASDAQ:LUCY) shares moved upwards by 421.5% to $0.97 during Monday's regular session. The company's market cap stands at $16.9 million. OneMedNet (NASDAQ:ONMD) shares moved upwards by 55.78% to $2.29. The company's market cap stands at $54.6 million. Qilian Intl Hldg Gr (NASDAQ:QLI) shares moved upwards by 37.59% to $0.91. The company's market cap stands at $32.4 million. Onconetix (NASDAQ:ONCO) shares moved upwards by 29.7% to $0.18. The market value of their outstanding shares is at $4.0 million. TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 28.77% to $1.79. The company's market cap stands at $11.8 million. MultiPlan (NYSE:MPLN) stock rose 2
Gainers IGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDAQ:AHG) stock moved upwards by 21.96% to $1.05. The company's market cap stands at $153.8 million. MultiPlan (NYSE:MPLN) shares rose 18.57% to $0.64. The company's market cap stands at $415.4 million. Cyclerion Therapeutics (NASDAQ:CYCN) shares rose 14.61% to $2.98. The company's market cap stands at $7.4 million. TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 12.79% to $1.41. The company's market cap stands at $9.3 million. Indaptus Therapeutics (NASDAQ:INDP) shares moved upward
The Dow Jones index closed lower by 0.5% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform. MultiPlan The Trade: MultiPlan Corporation (NYSE:MPLN) Director Anthony Colaluca Jr bought a total of 160,000 shares at an average price of $0.60. To acquire these shares, it cost around $96,000. What's Happening: On May 8, MultiPlan posted a GAAP loss of